{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:43:35Z","timestamp":1774122215597,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011581","name":"Indian Institute of Technology Indore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40268-020-00312-5","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T20:13:13Z","timestamp":1593202393000},"page":"161-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells"],"prefix":"10.1007","volume":"20","author":[{"given":"Mirza S.","family":"Baig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manikandan","family":"Alagumuthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjan","family":"Rajpoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzma","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"issue":"10143","key":"312_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(18)31443-0","volume":"392","author":"JA Lewnard","year":"2018","unstructured":"Lewnard JA. Ebola virus disease: 11 323 deaths later, how far have we come? Lancet. 2018;392(10143):189\u201390.","journal-title":"Lancet"},{"key":"312_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","volume":"130","author":"SC Weaver","year":"2016","unstructured":"Weaver SC, Costa F, Garcia-Blanco MA, Ko AI, Ribeiro GS, Saade G, et al. Zika virus: history, emergence, biology, and prospects for control. Antiviral Res. 2016;130:69\u201380.","journal-title":"Antiviral Res"},{"issue":"3","key":"312_CR3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s13337-013-0171-y","volume":"24","author":"DD Kulkarni","year":"2013","unstructured":"Kulkarni DD, Tosh C, Venkatesh G, Senthil KD. Nipah virus infection: current scenario. Indian J Virol. 2013;24(3):398\u2013408.","journal-title":"Indian J Virol"},{"issue":"10136","key":"312_CR4","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/S0140-6736(18)31252-2","volume":"391","author":"P Chatterjee","year":"2018","unstructured":"Chatterjee P. Nipah virus outbreak in India. Lancet. 2018;391(10136):2200.","journal-title":"Lancet"},{"issue":"1447","key":"312_CR5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1098\/rstb.2004.1490","volume":"359","author":"RM Anderson","year":"2004","unstructured":"Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, et al. Epidemiology, transmission dynamics and control of SARS: the 2002\u20132003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004;359(1447):1091\u2013105.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"9","key":"312_CR6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1408636","volume":"372","author":"IK Oboho","year":"2015","unstructured":"Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, et al. 2014 MERS-CoV outbreak in Jeddah: a link to health care facilities. N Engl J Med. 2015;372(9):846\u201354.","journal-title":"N Engl J Med"},{"issue":"1","key":"312_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","volume":"76","author":"NP Johnson","year":"2002","unstructured":"Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918\u20131920 \"Spanish\" influenza pandemic. Bull Hist Med. 2002;76(1):105\u201315.","journal-title":"Bull Hist Med"},{"issue":"1","key":"312_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","volume":"12","author":"JK Taubenberger","year":"2006","unstructured":"Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12(1):15\u201322.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"312_CR9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/JCMA.0000000000000270","volume":"83","author":"YC Wu","year":"2020","unstructured":"Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc. 2020;83(3):217\u201320.","journal-title":"J Chin Med Assoc"},{"issue":"7","key":"312_CR10","first-page":"4016","volume":"24","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016\u201326.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"312_CR11","volume-title":"Features, evaluation and treatment coronavirus (COVID-19)","author":"M Cascella","year":"2020","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Treasure Island: StatPearls; 2020."},{"issue":"10223","key":"312_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497\u2013506.","journal-title":"China Lancet"},{"issue":"6493","key":"312_CR13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.abb5793","volume":"368","author":"SM Kissler","year":"2020","unstructured":"Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368(6493):860\u20138.","journal-title":"Science"},{"key":"312_CR14","doi-asserted-by":"crossref","unstructured":"Uddin M, Mustafa F, Rizvi TA, Loney T, Al Suwaidi H, Al Marzouqi A, et al. SARS-CoV-2\/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. 2020","DOI":"10.20944\/preprints202004.0005.v1"},{"key":"312_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1\u201323.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"312_CR16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424\u201332.","journal-title":"J Med Virol"},{"issue":"1","key":"312_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237\u201361.","journal-title":"Annu Rev Virol"},{"issue":"5742","key":"312_CR18","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309(5742):1864\u20138.","journal-title":"Science"},{"issue":"6485","key":"312_CR19","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444\u20138.","journal-title":"Science"},{"issue":"2","key":"312_CR20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u201380e8.","journal-title":"Cell"},{"issue":"7798","key":"312_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133.","journal-title":"Nature"},{"issue":"10224","key":"312_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565\u201374.","journal-title":"Lancet"},{"key":"312_CR23","doi-asserted-by":"crossref","unstructured":"Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular & molecular immunology. Epub 19 Mar 2020. doi: 10.1038\/s41423-020-0400-4","DOI":"10.1038\/s41423-020-0400-4"},{"key":"312_CR24","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"B Coutard","year":"2020","unstructured":"Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir Res. 2020;176:104742.","journal-title":"Antivir Res"},{"issue":"2","key":"312_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 Spike glycoprotein. Cell. 2020;181(2):281\u201392e6.","journal-title":"Cell"},{"issue":"4","key":"312_CR26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586\u201390.","journal-title":"Intensive Care Med"},{"issue":"9","key":"312_CR27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-2828(03)00177-9","volume":"35","author":"M Donoghue","year":"2003","unstructured":"Donoghue M, Wakimoto H, Maguire CT, Acton S, Hales P, Stagliano N, et al. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol. 2003;35(9):1043\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"312_CR28","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, thereceptor of SARS-CoV-2. bioRxiv; 2020. https:\/\/www.biorxiv.org\/content\/10.1101\/2020.01.26.919985v2","DOI":"10.1101\/2020.01.26.919985"},{"issue":"1","key":"312_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1183\/09031936.00015612","volume":"42","author":"BD Uhal","year":"2013","unstructured":"Uhal BD, Dang M, Dang V, Llatos R, Cano E, Abdul-Hafez A, et al. Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis. Eur Respir J. 2013;42(1):198\u201321010.","journal-title":"Eur Respir J"},{"issue":"6891","key":"312_CR30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822\u20138.","journal-title":"Nature"},{"issue":"20","key":"312_CR31","doi-asserted-by":"crossref","first-page":"17132","DOI":"10.1074\/jbc.M006723200","volume":"276","author":"H Zhang","year":"2001","unstructured":"Zhang H, Wada J, Hida K, Tsuchiyama Y, Hiragushi K, Shikata K, et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem. 2001;276(20):17132\u20139.","journal-title":"J Biol Chem"},{"issue":"14","key":"312_CR32","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000094734.67990.99","volume":"108","author":"LS Zisman","year":"2003","unstructured":"Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, et al. Increased angiotensin-(1\u20137)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation. 2003;108(14):1707\u201312.","journal-title":"Circulation"},{"key":"312_CR33","unstructured":"Zhou Q, Yan R, Zhang Y, Li Y, Xia L. Structure of dimeric full-length human ACE2 in complex with B0AT1. BioRxiv. 2020. https:\/\/www.biorxiv.org\/content\/10.1101\/2020.02.17.951848v1.full."},{"issue":"8","key":"312_CR34","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1096\/fj.08-107300","volume":"22","author":"S Kowalczuk","year":"2008","unstructured":"Kowalczuk S, Broer A, Tietze N, Vanslambrouck JM, Rasko JE, Broer S. A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB J. 2008;22(8):2880\u20137.","journal-title":"FASEB J"},{"issue":"9","key":"312_CR35","doi-asserted-by":"crossref","first-page":"e0184845","DOI":"10.1371\/journal.pone.0184845","volume":"12","author":"J Jando","year":"2017","unstructured":"Jando J, Camargo SMR, Herzog B, Verrey F. Expression and regulation of the neutral amino acid transporter B0AT1 in rat small intestine. PLoS ONE. 2017;12(9):e0184845.","journal-title":"PLoS ONE"},{"issue":"Pt 3","key":"312_CR36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1042\/BJ20050083","volume":"389","author":"C Bohmer","year":"2005","unstructured":"Bohmer C, Broer A, Munzinger M, Kowalczuk S, Rasko JE, Lang F, et al. Characterization of mouse amino acid transporter B0AT1 (slc6a19). Biochem J. 2005;389(Pt 3):745\u201351.","journal-title":"Biochem J"},{"issue":"7408","key":"312_CR37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477\u201381.","journal-title":"Nature"},{"issue":"3","key":"312_CR38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.gastro.2008.10.055","volume":"136","author":"SM Camargo","year":"2009","unstructured":"Camargo SM, Singer D, Makrides V, Huggel K, Pos KM, Wagner CA, et al. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology. 2009;136(3):872\u201382.","journal-title":"Gastroenterology"},{"key":"312_CR39","doi-asserted-by":"crossref","unstructured":"Procko E. The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2. bioRxiv. 2020. https:\/\/www.biorxiv.org\/content\/10.1101\/2020.03.16.994236v1.","DOI":"10.1101\/2020.03.16.994236"},{"issue":"4","key":"312_CR40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V, Kwon H, Prado P, Hagelkr\u00fcys A, Wimmer RA, Stahl M, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181(4):905\u201313.","journal-title":"Cell"},{"key":"312_CR41","doi-asserted-by":"crossref","unstructured":"Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. Journal of medical virology. Epub 27 Feb 2020. 10.1002\/jmv.25727.","DOI":"10.1002\/jmv.25727"},{"key":"312_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","volume":"6","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. 2020;6:14.","journal-title":"Cell Discov"},{"key":"312_CR43","doi-asserted-by":"crossref","unstructured":"Chen YW, Yiu CB, Wong KY. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research. 2020;9:129.","DOI":"10.12688\/f1000research.22457.2"},{"key":"312_CR44","doi-asserted-by":"crossref","unstructured":"Gurwitz D. Angiotensin receptor blockers as tentative SARS\u2010CoV\u20102 therapeutics. Drug Dev Res. Epub 4 Mar 2020. doi: 10.1002\/ddr.21656.","DOI":"10.1002\/ddr.21656"},{"key":"312_CR45","doi-asserted-by":"crossref","unstructured":"Robson B. Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus. Comput Biol Med. 2020;119:103670.","DOI":"10.1016\/j.compbiomed.2020.103670"},{"issue":"6","key":"312_CR46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jmv.25736","volume":"92","author":"M Bhattacharya","year":"2020","unstructured":"Bhattacharya M, Sharma AR, Patra P, Ghosh P, Sharma G, Patra BC, et al. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020;92(6):618\u201331.","journal-title":"J Med Virol"},{"key":"312_CR47","doi-asserted-by":"crossref","unstructured":"Hussain M, Jabeen N, Raza F, Shabbir S, Baig AA, Amanullah A, et al. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J Med Virol. Epub 6 Apr 2020. doi: 10.1002\/jmv.25832.","DOI":"10.1002\/jmv.25832"},{"key":"312_CR48","doi-asserted-by":"crossref","unstructured":"Pant S, Singh M, Ravichandiran V, Murty USN, Srivastava HK. Peptide-like and small-molecule inhibitors against Covid-19. J Biomol Struct Dyn. Epub 6 May 2020. doi: 10.1080\/07391102.2020.1757510.","DOI":"10.1080\/07391102.2020.1757510"},{"issue":"4","key":"312_CR49","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1021\/acsnano.0c02857","volume":"14","author":"Y Han","year":"2020","unstructured":"Han Y, Kral P. Computational design of ACE2-based peptide inhibitors of SARS-CoV-2. ACS Nano. 2020;14(4):5143\u20137.","journal-title":"ACS Nano"},{"key":"312_CR50","unstructured":"Syst\u00e8mes DB. Discovery Studio Modeling Environment, Release 2019. Dassault Syst\u00e8mes; 2019."},{"issue":"13","key":"312_CR51","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera: a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312.","journal-title":"J Comput Chem"},{"issue":"13","key":"312_CR52","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/bioinformatics\/btt262","volume":"29","author":"B Jimenez-Garcia","year":"2013","unstructured":"Jimenez-Garcia B, Pons C, Fernandez-Recio J. pyDockWEB: a web server for rigid-body protein-protein docking using electrostatics and desolvation scoring. Bioinformatics. 2013;29(13):1698\u20139.","journal-title":"Bioinformatics"},{"key":"312_CR53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-0366-5_12","volume":"1137","author":"GC van Zundert","year":"2014","unstructured":"van Zundert GC, Bonvin AM. Modeling protein-protein complexes using the HADDOCK webserver \"modeling protein complexes with HADDOCK\". Methods Mol Biol. 2014;1137:163\u201379.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"312_CR54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/prot.10389","volume":"52","author":"R Chen","year":"2003","unstructured":"Chen R, Li L, Weng Z. ZDOCK: an initial-stage protein-docking algorithm. Proteins. 2003;52(1):80\u20137.","journal-title":"Proteins"},{"key":"312_CR55","doi-asserted-by":"crossref","unstructured":"Pronk S, Pall S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7):845\u201354.","DOI":"10.1093\/bioinformatics\/btt055"},{"key":"312_CR56","doi-asserted-by":"crossref","unstructured":"Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Open Source Drug Discovery C, et al. In silico approach for predicting toxicity of peptides and proteins. PloS One. 2013;8(9):e73957.","DOI":"10.1371\/journal.pone.0073957"},{"key":"312_CR57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The proteomics protocols handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. In: Walker JM, editor. The proteomics protocols handbook. New York: Springer; 2005. p. 571\u2013607."},{"issue":"9","key":"312_CR58","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138161212799436412","volume":"18","author":"JK Morrow","year":"2012","unstructured":"Morrow JK, Zhang S. Computational prediction of protein hot spot residues. Curr Pharm Des. 2012;18(9):1255\u201365.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"312_CR59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0959-440X(02)00283-X","volume":"12","author":"WL DeLano","year":"2002","unstructured":"DeLano WL. Unraveling hot spots in binding interfaces: progress and challenges. Curr Opin Struct Biol. 2002;12(1):14\u201320.","journal-title":"Curr Opin Struct Biol"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-020-00312-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:21:13Z","timestamp":1624663273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-020-00312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1007\/s40268-020-00312-5","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"26 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study is supported by the Indian Institute of Technology Indore (IITI) India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"MSB, MA, SR and US declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}